Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths
Top Cited Papers
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 40 (11) , 715-724
- https://doi.org/10.1097/01.rli.0000184756.66360.d3
Abstract
To characterize and compare commercially available contrast media (CM) for magnetic resonance imaging (MRI) in terms of their relaxivity at magnetic field strengths ranging from 0.47 T to 4.7 T at physiological temperatures in water and in plasma. Relaxivities also were quantified in whole blood at1.5 T. Relaxivities of MRI-CM were determined by nuclear magnetic resonance (NMR) spectroscopy at 0.47 T and MRI phantom measurements at 1.5 T, 3 T, and 4.7 T, respectively. Both longitudinal (T1) and transverse relaxation times (T2) were measured by appropriate spin-echo sequences. Nuclear magnetic resonance dispersion (NMRD) profiles were also determined for all agents in water and in plasma. Significant dependencies of relaxivities on the field strength and solvents were quantified. Protein binding leads to both increased field strength and solvent dependencies and hence to significantly altered T1 relaxivity values at higher magnetic field strengths. Awareness of the field strength and solvent associated with relaxivity data is crucial for the comparison and evaluation of relaxivity values. Data observed at 0.47 T can thus be misleading and should be replaced by relaxivities measured at 1.5 T and at 3 T in plasma at physiological temperature.Keywords
This publication has 44 references indexed in Scilit:
- Renal Functional Contrast-Enhanced Magnetic Resonance ImagingInvestigative Radiology, 2005
- In and Ex Vivo MR Evaluation of Acute Myocardial Ischemia in Pigs by Determining R1 in Steady State After the Administration of the Intravascular Contrast Agent NC100150 InjectionInvestigative Radiology, 2004
- Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance ImagingInvestigative Radiology, 2004
- Gadobutrol, a highly concentrated MR imaging contrast agent: its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and in perfusion imagingEuropean Radiology Supplements, 2004
- Contrast-Enhanced Three-Dimensional Pulmonary Perfusion Magnetic Resonance ImagingInvestigative Radiology, 2004
- Using a 1 M Gd‐chelate (gadobutrol) for total‐body three‐dimensional MR angiography: Preliminary experienceJournal of Magnetic Resonance Imaging, 2003
- Intraindividual Comparison of Gadopentetate Dimeglumine, Gadobenate Dimeglumine, and Gadobutrol for Pelvic 3D Magnetic Resonance AngiographyInvestigative Radiology, 2003
- Gadobenate Dimeglumine (Gd-BOPTA)Investigative Radiology, 1998
- UpdateTopics in Magnetic Resonance Imaging, 1995
- Phase III clinical evaluation of Gd-HP-DO3A in head and spine diseaseJournal of Magnetic Resonance Imaging, 1991